GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UXN Co Ltd (XKRX:337840) » Definitions » COGS-to-Revenue

UXN Co (XKRX:337840) COGS-to-Revenue : 0.34 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is UXN Co COGS-to-Revenue?

UXN Co's Cost of Goods Sold for the six months ended in Dec. 2024 was ₩174.1 Mil. Its Revenue for the six months ended in Dec. 2024 was ₩513.5 Mil.

UXN Co's COGS to Revenue for the six months ended in Dec. 2024 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. UXN Co's Gross Margin % for the six months ended in Dec. 2024 was 66.09%.

UXN Co COGS-to-Revenue Historical Data

The historical data trend for UXN Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UXN Co COGS-to-Revenue Chart

UXN Co Annual Data
Trend Dec22 Dec23 Dec24
COGS-to-Revenue
0.80 0.35 0.34

UXN Co Semi-Annual Data
Dec22 Dec23 Dec24
COGS-to-Revenue 0.80 0.35 0.34

UXN Co COGS-to-Revenue Calculation

UXN Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=174.137 / 513.465
=0.34

UXN Co's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=174.137 / 513.465
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UXN Co  (XKRX:337840) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

UXN Co's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 174.137 / 513.465
=66.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

UXN Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of UXN Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

UXN Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UXN Co Ltd (XKRX:337840) » Definitions » COGS-to-Revenue
Comparable Companies
XKRX:115480 XKRX:419540 XKRX:214610 XKRX:290660 XKRX:387570 XKRX:398120 XKRX:335810 XKRX:238120 XKRX:200580 XKRX:058110 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
No. 614, No. 1, 379, Green-ro, Jeollanam-do, Naju, KOR, 58325
Website
http://www.uxn.co.kr
UXN Co Ltd is a medical device company. It is engaged in the production of Blood glucose sensors, and blood glucose meter.

UXN Co Headlines

No Headlines